Alnylam Pharmaceuticals
ALNY
#579
Rank
A$53.20 B
Marketcap
$414.46
Share price
1.16%
Change (1 day)
53.61%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividends for this company